Showing Results for
- Academic Journals (1,858)
Search Results
- 1,858
Academic Journals
- 1,858
-
From:Oman Journal of Ophthalmology (Vol. 6, Issue 1) Peer-Reviewed
Nodular episcleritis after laser in situ keratomileusis in patient with systemic lupus erythematosus
Byline: Mohammad. Al-Amry Sir, Laser in situ keratomileusis (LASIK) is safe and efficacious for the treatment of refractive error. However, controversy remains regarding LASIK for patients with autoimmune... -
From:Neurology India (Vol. 62, Issue 3) Peer-ReviewedByline: Payam. Sasannejad, Nahid. Olfati, Mohsen. Sabi, Ali. Juibary Sir, One-and-a-half syndrome (OHS) is characterized by an internuclear ophthalmoplegia (INO) and lateral gaze palsy due to the involvement of...
-
From:Pediatric Nephrology (Vol. 30, Issue 1) Peer-ReviewedBackground Treatment of systemic lupus erythematosus (SLE) with severe diffuse proliferative nephritis is often challenging, particularly in small children in whom a genetic conditioning is likely to play a role. The...
-
From:Saudi Journal of Kidney Diseases and Transplantation (Vol. 26, Issue 3) Peer-ReviewedByline: Tamer. Gheita, Abeer. Abd El Baky, Heba. Assal, Tarek. Farid, Inas. Rasheed, Eman. Thabet Lupus nephritis (LN) is a potentially devastating outcome of systemic lupus erythematosus (SLE). It is important to...
-
From:Egyptian Rheumatology and Rehabilitation (Vol. 42, Issue 2) Peer-ReviewedByline: Mahmoud. Fathalla, Mohja. El-Badawy Background Systemic lupus erythematosus (SLE) is an autoimmune, multiorgan disease that affects connective tissues of many organs or systems, including the nervous system,...
-
From:BioMed Research InternationalPeer-ReviewedBackground. Antioxidative capacity plays an important role in the severity of systemic lupus erythematosus (SLE), which is characterized by autoantibodies. This study aimed to determine the relationship among...
-
From:Indian Journal of Psychological Medicine (Vol. 34, Issue 1)Byline: Rajiv. Radhakrishnan, Jayakumar. Menon, Milanduth. Kanigere, Mysore. Ashok, Vineeta. Shobha, R. Galgali Background: The World Health Organization Quality of Life-Bref (WHOQOL-Bref) scale was designed to...
-
From:Clinical and Developmental ImmunologyPeer-ReviewedTwo streams of research are at the origin of the utilization of hematopoietic stem cell transplantation (HSCT) for severe autoimmune diseases (SADs). The allogeneic approach came from experimental studies on lupus mice,...
-
From:Clinical and Developmental ImmunologyPeer-ReviewedOsteopontin is a proinflammatory molecule, modulating TH1 and TH17 responses. Several reports suggest its involvement in multiple sclerosis (MS) pathogenesis. We previously reported that OPN gene variations at the 3'...
-
From:The Journal of Musculoskeletal Medicine (Vol. 28, Issue 2) Peer-ReviewedDogdu O, Yarlioglues M, Kaya MG, et al, Erciyes University School of Medicine, Kayseri, Turkey, and Gaziosmanpasa University School of Medicine, Tokat, Turkey. Deterioration of heart rate recovery index in patients with...
-
From:Archives of Neuropsychiatry (Vol. 47, Issue 1) Peer-ReviewedA 68-year-old woman presented with subacute onset of limbic symptoms, cerebellar ataxia and polyneuropathy. While the initial findings were suggestive of a paraneoplastic syndrome, she later developed liver and kidney...
-
From:International Journal of Clinical Rheumatology (Vol. 4, Issue 3) Peer-ReviewedAuthor(s): John A Reynolds 1 , Ian N Bruce [[dagger]] 1 KEYWORDS: autoimmunity; calcitriol; cardiovascular disease; musculoskeletal pain; SLE; systemic lupus erythematosus; vitamin D Systemic lupus...
-
From:International Journal of Clinical Rheumatology (Vol. 5, Issue 3) Peer-ReviewedAuthor(s): Sofia de Achaval 1 , Maria E Suarez-Almazor [[dagger]] 2 KEYWORDS: adherence; disease-modifying antirheumatic drugs; rheumatoid arthritis; systematic review; systemic lupus erythematosus Treatment...
-
From:Reactions Weekly (Issue 1276)[*] A 71-year-old woman developed lupus erythematosus tumidus (LET) while receiving bortezomib for multiple myeloma. Following diagnosis of stage IIIA disease in 2007, the woman received cycles of therapy...
-
From:Reactions Weekly (Issue 1253)A 24-year-old woman developed interstitial pneumonitis after receiving rituximab for systemic lupus erythematosus (SLE). The woman's SLE was initially treated with IV methylprednisolone pulse therapy and oral...
-
From:Women's Health (Vol. 3, Issue 4) Peer-ReviewedAuthor(s): Alessandra Graziottin 1 Keywords: arousal disorders; cancer survivors; desire disorders; dyspareunia; estrogen; hormone therapy; infertility; premature menopause; sexual dysfunction; testosterone...
-
From:Expert Review of Clinical Immunology (Vol. 2, Issue 1) Peer-ReviewedAuthor(s): Gary Kunkel [[dagger]] 1 , Grant W Cannon 1 Keywords: clinical trials; juvenile rheumatoid arthritis; leflunomide; rheumatoid arthritis Rheumatoid arthritis (RA) is a chronic, disabling disease that...
-
From:Expert Review of Dermatology (Vol. 1, Issue 1) Peer-ReviewedAuthor(s): Jennie T Clarke 1 , Victoria P Werth [[dagger]] 2 Keywords: antimalarial therapy; biological therapy; cutaneous lupus; dapsone therapy; erythematosus; immunosuppressant therapy; retinoid therapy;...
-
From:Pharmacogenomics (Vol. 7, Issue 2) Peer-ReviewedAuthor(s): Michael E Burczynski [1[dagger]] , Andrew J Dorner Keywords: biomarkers; clinical pharmacogenomics; cell purification tubes; hemogenomics; molecular diagnostics; peripheral blood mononuclear cells;...
-
From:Future Rheumatology (Vol. 1, Issue 3) Peer-ReviewedAuthor(s): Ronald A Asherson 1 , Ricard Cervera 2 , Joan T Merrill 3 Keywords: antiphospholipid antibodies; Asherson's syndrome; HELLP syndrome; microangiopathic antiphospholipid syndrome; thrombotic...